1. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Issue 1 (26th March 2020) Authors: Jühling, Frank; Hamdane, Nourdine; Crouchet, Emilie; Li, Shen; El Saghire, Houssein; Mukherji, Atish; Fujiwara, Naoto; Oudot, Marine A; Thumann, Christine; Saviano, Antonio; Roca Suarez, Armando Andres; Goto, Kaku; Masia, Ricard; Sojoodi, Mozhdeh; Arora, Gunisha; Aikata, Hiroshi; Ono, Atsushi; Ta... Journal: Gut Issue: Volume 70:Issue 1(2021) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma. Issue 1 (26th March 2020) Authors: Jühling, Frank; Hamdane, Nourdine; Crouchet, Emilie; Li, Shen; El Saghire, Houssein; Mukherji, Atish; Fujiwara, Naoto; Oudot, Marine A; Thumann, Christine; Saviano, Antonio; Roca Suarez, Armando Andres; Goto, Kaku; Masia, Ricard; Sojoodi, Mozhdeh; Arora, Gunisha; Aikata, Hiroshi; Ono, Atsushi; Ta... Journal: Gut Issue: Volume 70:Issue 1(2021) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction. Issue 6 (18th March 2019) Authors: Li, Shen; Ghoshal, Sarani; Sojoodi, Mozhdeh; Arora, Gunisha; Masia, Ricard; Erstad, Derek J.; Ferriera, Diego S.; Li, Yang; Wang, Guogiang; Lanuti, Michael; Caravan, Peter; Or, Yat Sun; Jiang, Li-Juan; Tanabe, Kenneth K.; Fuchs, Bryan C. Journal: FASEB journal Issue: Volume 33:Issue 6(2019) Page Start: 7103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗